Pharmaceutical company Boehringer Ingelheim’s largest manufacturing site in the US is now powered solely by renewable energy.
It has signed a 10-year contract with Evergy to buy energy generated at a wind farm in Kansas for its site in St. Joseph, Missouri, which manufactures vaccines for horses, pigs, cattle and other animals.
The switch to wind power is expected to help reduce carbon emissions at the site by 76%.
Another Boehringer Ingelheim Animal Health research and development site in North Brunswick has transitioned to renewable energy by purchasing green power and a poultry-vaccine manufacturing plant in Gainesville is on track to becoming its first major US production site to go carbon neutral.
The company’s headquarters in Ridgefield, Connecticut, which employs around 2,500 people, also transitioned to renewable energy last year.
Jean-Michel Boers, President and CEO said: “From reducing our carbon footprint to reducing the amount of electricity and water we use, we are dedicated to providing a more sustainable future for the people and animals we serve and the communities where we live and work.”